Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy

Neurology

Volumn 73, Issue 20, 2009, Pages 1707-1708

  McMaster, J ^a   Gibson, G ^a   Castro Prado, F ^a   Vitali, A ^a   Honey, C R ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY MYELIN ASSOCIATED GLYCOPROTEIN; CYCLOPHOSPHAMIDE; GABAPENTIN; MYELIN ASSOCIATED GLYCOPROTEIN; PRIMIDONE; PROPRANOLOL; PROTEIN ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; ELECTROSTIMULATION; FEMALE; HUMAN; HYGIENE; NEUROPATHY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREMOR;

EID: 73449110503     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c1de66     Document Type: Article

References (7)

1. Blume G, Pestronk A, Goodnough LT. Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology 1995;45:1577-1580.
2. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinemic neuropathy. Brain 1996;119:789-799.
3. Ruzicka E, Jech R, Zarubova K, Roth J, Urgosik D. VIM thalamic stimulation for tremor in a patient with IgM paraproteinemic demyelinating neuropathy. Mov Disord 2003;18:1192-1195.
4. Murray N, Page N, Steck AJ. The human anti-myelin-associated glycoprotein IgM system. Ann Neurol 1986;19: 473-478.
5. Cook D, Dalakas M, Galdi A, Biondi D, Porter H. High-dose intravenous immunoglobulin in the treatment of de-myelinating neuropathy associated with monoclonal gammopathy. Neurology 1990;40:212-214.
6. Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, Levine TD. Treatment of IgM antibody associated polyneuropathies using rituximab. JNNP 2003;74:485-489.
7. Said G, Bathien N, Cesaro P. Peripheral neuropathies and tremor. Neurology 1982;32:480-485.